Physician profile
John O Barton
NPI 1831130087
$2,090.74
in general payments reported to CMS, 2019-2025
18 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $141 · 2021: $245 · 2022: $533 · 2023: $405 · 2024: $370 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571 · Education: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.22 |
| Education | $409.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $489.84 | 2020-2025 | Tremfya |
| Abbvie INC. | $466.02 | 2021-2024 | Rinvoq, Skyrizi |
| Sun Pharmaceutical Industries INC. | $274.60 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $160.34 | 2020-2024 | |
| Regeneron Healthcare Solutions, INC. | $141.25 | 2020-2024 | Dupixent, Libtayo |
| Pfizer INC. | $122.60 | 2019-2023 | |
| Leo Pharma INC. | $92.19 | 2022-2023 | Adbry |
| Galderma Laboratories, L.P. | $74.06 | 2019-2025 | Nemluvio |
| Janssen Scientific Affairs, LLC | $49.61 | 2019 | |
| Almirall LLC | $38.07 | 2019-2025 | Klisyri |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $36.28 | 2019-2020 | |
| Genentech USA, INC. | $33.03 | 2023-2024 | Erivedge |
| Ucb, INC. | $26.67 | 2023 | Cimzia |
| Helsinn Therapeutics (U.S.), INC. | $25.13 | 2019-2021 | |
| Genzyme Corporation | $22.47 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $13.94 | 2021 | |
| Incyte Corporation | $13.55 | 2021 | |
| Allergan, INC. | $11.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.